Use of Daratumumab in Patients With Previously Treated Multiple Myeloma

被引：0
|
作者：
Patel, Ashwin P. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 14期
关键词：
D O I：
10.1200/JCO.22.02850
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis
    Jiasheng Wang
    Yeseong Kim
    International Journal of Hematology, 2020, 112 : 650 - 657
  • [42] CD38 Expression Loss in Multiple Myeloma Treated with Daratumumab
    Hotchandani, Nihar
    Fung, Henry
    Dulaimi, Essel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [43] Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone
    Sato, Shuku
    Kambe, Emiko
    Tamai, Yotaro
    INTERNAL MEDICINE, 2019, 58 (06) : 843 - 847
  • [44] Daratumumab for the Treatment of Multiple Myeloma
    Plesner, Torben
    Krejcik, Jakub
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [45] Daratumumab for the treatment of multiple myeloma
    Touzeau, Cyrille
    Moreau, Philippe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (07) : 887 - 893
  • [46] Daratumumab in multiple myeloma: a guide to its use as monotherapy in the EU
    McKeage K.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (11) : 463 - 469
  • [47] Daratumumab for the treatment of multiple myeloma
    Goldsmith, S. R.
    Foley, N.
    Schroeder, M. A.
    DRUGS OF TODAY, 2021, 57 (10) : 591 - 605
  • [48] Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy
    Casneuf, Tineke
    Lysaght, Andrew
    LeFave, Clare
    Bald, Jaime
    Weiss, Brendan
    van de Donk, Niels W. C. J.
    Lokhorst, Henk M.
    Ahmadi, Tahamtan
    Sasser, A. Kate
    BLOOD, 2015, 126 (23)
  • [49] Daratumumab: Beyond Multiple Myeloma
    Ejaz, Kiran
    Roback, John D.
    Stowell, Sean R.
    Sullivan, Harold C.
    TRANSFUSION MEDICINE REVIEWS, 2021, 35 (03) : 36 - 43
  • [50] A retrospective single-centre cohort study of the efficacy and safety of daratumumab with bortezomib and dexamethasone therapy for previously treated multiple myeloma
    Sanchez, I.
    Milner, G.
    El-Najjar, I.
    Sachchinanantham, S.
    Gleeson, M.
    Kazmi, M.
    Bailey, K.
    Benjamin, R.
    Cuthill, H.
    Yuen, L.
    Streetly, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 179 - 180
12345